Catumaxomab treatment in gastric-cancer patients with malignant ascites - subgroup-analysis of a pivotal trial

被引：2
|
作者：
Heiss, M. [1 ]
Linke, R. [2 ]
Friccius-Quecke, H. [2 ]
Klein, A. [3 ]
Hennig, M. [4 ]
Lindhofer, H. [5 ]
Parsons, S. [6 ]
机构：
[1] Merheim Med Ctr, Cologne, Germany
[2] Fresenius Biotech GmbH, Clin Dev, Munich, Germany
[3] Fresenius Biotech GmbH, Med Affairs, Munich, Germany
[4] Fresenius Biotech GmbH, Biostat, Munich, Germany
[5] TRION Pharma GmbH, Munich, Germany
[6] City Hosp Nottingham, Nottingham, England
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71229-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [1] Catumaxomab treatment in gastric-cancer patients with malignant ascites: subgroup-analysis of a pivotal trial
    Heiss, M. M.
    Linke, R.
    Klein, A.
    Friccius-Quecke, H.
    Hennig, M.
    Lindhofer, H.
    Parsons, S.
    ONKOLOGIE, 2010, 33 : 76 - 76
  • [2] CATUMAXOMAB - A NEW TREATMENT OPTION FOR PATIENTS WITH MALIGNANT ASCITES
    Heiss, M.
    Linke, R.
    Schulze, E.
    Friccius-Quecke, H.
    Hennig, M.
    Gamperl, H.
    Lindhofer, H.
    Parsons, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 12 - 12
  • [3] AGGRESSIVE IMMUNOCHEMOTHERAPY FOR GASTRIC-CANCER WITH MALIGNANT ASCITES
    IWASAKI, K
    TORISU, M
    HANADA, M
    YOSHIDA, T
    NEW HORIZONS OF TUMOR IMMUNOTHERAPY, 1989, 852 : 569 - 580
  • [4] The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature
    Tsikouras, Panagiotis
    Tsagias, Nikolaos
    Pinidis, Petros
    Csorba, Roland
    Vrachnis, Nikolaos
    Dafopoulos, Alexandros
    Bouchlariotou, Sophia
    Liberis, Anastasios
    Teichmann, Alexander Tobias
    von Tempelhoff, Georg Friedrich
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (03) : 581 - 585
  • [5] The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature
    Panagiotis Tsikouras
    Nikolaos Tsagias
    Petros Pinidis
    Roland Csorba
    Nikolaos Vrachnis
    Alexandros Dafopoulos
    Sophia Bouchlariotou
    Anastasios Liberis
    Alexander Tobias Teichmann
    Georg Friedrich von Tempelhoff
    Archives of Gynecology and Obstetrics, 2013, 288 : 581 - 585
  • [6] Clinical benefit of catumaxomab in malignant ascites in patient subpopulations in a pivotal phase II/III trial
    Parsons, S.
    Hennig, M.
    Linke, R.
    Klein, A.
    Lahr, A.
    Lindhofer, H.
    Heiss, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Treatment of malignant ascites with catumaxomab in clinical practice: Results of an observational trial
    Kurbacher, C.
    Sehouli, J.
    Welslau, M.
    von Tempelhoff, G-F
    Kuhfahl, J.
    Marth, C.
    Oettle, H.
    Schmalfeldt, B.
    Schulze, E.
    Kunzmann, V
    ONKOLOGIE, 2013, 36 : 280 - 280
  • [8] Quality of life in patients with malignant ascites during catumaxomab treatment: Results from the CASIMAS trial
    Lordick, Florian
    Sehouli, Jalid
    Vergote, Ignace B.
    Rosenberg, Per
    Schneeweiss, Andreas
    Block, Andreas
    Salat, Christoph
    Scambia, Giovanni
    Berton-Rigaud, Dominique
    Siena, Salvatore
    Santoro, Armando
    Cervantes-Ruiperez, Andres
    Guastalla, Jean Paul
    Tournigand, Christophe
    Colombo, Nicoletta
    Dudnitchenko, Alexander Serg
    Bondar, Vladimir
    Westermann, A. M.
    Gonschior, Ann-Katrin
    Wimberger, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] The use of catumaxomab for treatment of malignant ascites in clinical practice: Results of an observational trial
    Kurbacher, C.
    Sehouli, J.
    Welslau, M.
    Tempelhofr, G. F.
    Kufahl, J.
    Marth, C.
    Oettle, H.
    Schmalfeldt, B.
    Schulze, E.
    Kunzmann, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S288 - S289
  • [10] Treatment with the trifunctional antibody catumaxomab followed by systemic chemotherapy: Results of a subgroup analysis from a phase III study in patients with relapsed ovarian cancer and malignant ascites
    Chekerov, R.
    Wimberger, P.
    Vergote, I.
    Schneeweiss, A.
    Scambia, G.
    Colombo, N.
    Guastalla, J. P.
    Lordick, F.
    Schulze, E.
    Sehouli, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S742 - S742
12345